The results showed that silencing PFDN4 has a greater ability to inhibit cell growth in triple-negative compared to non-triple-negative breast cancer cell lines (Figure 2B,C, p = 0.039). The gene discussed is PFDN4; the disease is triple-negative breast carcinoma.